BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31825376)

  • 41. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The enigma of Henry IV's disease: Did he suffer from McCune-Albright syndrome/fibrous dysplasia?].
    Tuñón Álvarez MT; Ruiz Calleja A; Pérez de Nanclares G
    Rev Esp Patol; 2023; 56(4):243-251. PubMed ID: 37879821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. McCune-Albright syndrome: growth hormone dynamics in pregnancy.
    Obuobie K; Mullik V; Jones C; John R; Rees AE; Davies JS; Scanlon MF; Lazarus JH
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2456-8. PubMed ID: 11397839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. McCune-Albright syndrome associated with pituitary adenoma: a clinicopathological study of ten cases and literature review.
    Li Z; Liu R; Liu P
    Br J Neurosurg; 2021 Oct; ():1-10. PubMed ID: 34632888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein.
    Gessl A; Freissmuth M; Czech T; Matula C; Hainfellner JA; Buchfelder M; Vierhapper H
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1128-34. PubMed ID: 7962285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.
    Sherman SI; Ladenson PW
    J Endocrinol Invest; 1992 Mar; 15(3):185-90. PubMed ID: 1624678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. McCune-Albright syndrome with acromegaly and fibrous dysplasia associated with the GNAS gene mutation identified by sensitive PNA-clamping method.
    Imanaka M; Iida K; Nishizawa H; Fukuoka H; Takeno R; Takahashi K; Kaji H; Takahashi Y; Okimura Y; Kaji H; Imanishi Y; Chihara K
    Intern Med; 2007; 46(18):1577-83. PubMed ID: 17878646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors.
    Mantovani G; Bondioni S; Lania AG; Corbetta S; de Sanctis L; Cappa M; Di Battista E; Chanson P; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3007-9. PubMed ID: 15181091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visual field improvement after pituitary tumor surgery in patients with McCune-Albright syndrome.
    Ma J; Zhao C; Wang R; Feng F; Wang E; You H; Jiang Y; Zhang M; Zhong Y
    J Neuroophthalmol; 2013 Mar; 33(1):26-9. PubMed ID: 23222370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth hormone-secreting pituitary adenoma associated with multiple bone cysts, skin pigmentation and aortitis syndrome.
    Ihara C; Shimatsu A; Murabe H; Kataoka K; Kondo C; Nakao K
    J Endocrinol Invest; 1996 Dec; 19(11):753-7. PubMed ID: 9061509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome.
    Geffner ME; Nagel RA; Dietrich RB; Kaplan SA
    J Pediatr; 1987 Nov; 111(5):740-3. PubMed ID: 2889819
    [No Abstract]   [Full Text] [Related]  

  • 52. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hyperthyroidism related to McCune-Albright syndrome: report of two cases and review of the literature].
    Sallum AC; Leonhardt FD; Cervantes O; Abrahão M; Yazaki RK
    Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):556-61. PubMed ID: 18506282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome.
    Dötsch J; Kiess W; Hänze J; Repp R; Lüdecke D; Blum WF; Rascher W
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3839-42. PubMed ID: 8923825
    [No Abstract]   [Full Text] [Related]  

  • 55. McCune-Albright syndrome in adulthood.
    Chanson P; Salenave S; Orcel P
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():453-62. PubMed ID: 17982395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anesthetic management of an acromegalic patient with McCune Albright syndrome for endoscopic transsphenoidal adenoma removal.
    Koc D; Bayri Y; Seker A
    J Neurosurg Anesthesiol; 2014 Jul; 26(3):267-9. PubMed ID: 24598473
    [No Abstract]   [Full Text] [Related]  

  • 57. [McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].
    Jung AJ; Soskin S; Paris F; Lipsker D
    Ann Dermatol Venereol; 2016 Jan; 143(1):21-6. PubMed ID: 26610360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [McCune-Albright syndrome: a difficult and complicated case study].
    Liang LY; Meng Z; Zeng QH; Li WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):311-4. PubMed ID: 16923365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Albright syndrome associated with acromegaly: report of a case and review of the literature.
    Lipson A; Hsu TH
    Johns Hopkins Med J; 1981 Jul; 149(1):10-4. PubMed ID: 7019531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
    Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
    N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.